ttos becoming more industry friendly
DESCRIPTION
TTOs Becoming More Industry Friendly. Bill cawley sr. vice president. Commercializing university research is important because it…. Provides a return for public investments in research Ensures that new & promising ideas are not trapped in the university laboratory - PowerPoint PPT PresentationTRANSCRIPT
1© 2010 Innovaro, Inc.
© 2010 Innovaro, Inc.
TTOs Becoming More Industry Friendly
BILL CAWLEY
SR. VICE PRESIDENT
2© 2010 Innovaro, Inc.
Commercializing university research is important because it… Provides a return for public investments in research
– Ensures that new & promising ideas are not trapped in the university laboratory
Drives new research funding– Creates tangible outputs from public investments
Provides a source of new start-up companies & technology related jobs– Contributes to economic renewal & competitiveness
Provides skills to companies within the innovation marketplace– Fosters resources needed for driving innovation
3© 2010 Innovaro, Inc.
However, we may have a problem
“Typically at present, negotiating a contract to perform collaborative research with an American university takes one to two years of exchanging emails by attorneys, punctuated by long telephone conference calls involving the scientists who wish to work together. All too often, the company spends more on attorneys’ fees than the value of the contract being negotiated. This situation has driven many large companies away from working with American universities altogether, and they are looking for alternate research partners.”
Stan Williams
Director, HP Quantum Science Research
4© 2010 Innovaro, Inc.
And there is global competition
Japan is restructuring its innovation system
China is focused on becoming leading edge in the R&D space
India is pursuing dramatic growth in IP related services
European countries are strategizing on how to provide alternatives to US university research
5© 2010 Innovaro, Inc.
“Of 3200 universities, perhaps 6 have made significant amounts of money from their intellectual property rights.”
John C. HurtNational Science Foundation
Let’s begin with understanding that the business models and drivers are different…
6© 2010 Innovaro, Inc.
A business model has some of the following major components:
Markets Risk Cost
Products Commercialization
Revenues
7© 2010 Innovaro, Inc.
“Innovation is the specific instrument of entrepreneurship: The act that endows resources with a new capacity to create wealth.” (Peter Drucker)
“Innovation is the central issue in economic prosperity” (Michel Porter)
“Continuing to innovate and staying closely connected to our consumers are key components in P&G’s strategy to continue growing in the face of toughening economic times.” (A.G. Lafley, 2009)
“Innovation matters because it can deliver better products and services, new, cleaner and more efficient production processes and improved business models. For businesses, innovation means sustained or improved growth. The innovative company or organization delivers higher profits for its owners and investors.” (DTI: Innovation Report, 2003)
“Look at the product pipeline, look at the fantastic financial results we've had for the last five years. You only get that kind of performance on the innovation side, on the financial side, if you're really listening and reacting to the best ideas of the people we have.” (Steve Ballmer)
Notice the focus on economics and wealth generation
8© 2010 Innovaro, Inc.
A university model has some of the following major components:
Faculty Investigators Students Research
Peer Reputation Publications
Grants
9© 2010 Innovaro, Inc.
University research receives funding primarily from the federal government
Funding Source
Mill
ion
s o
f U
SD
(ye
ar 2
000)
Sources: National Science Foundation, Division of Science Resources Statistics (NSF/SRS), Research and Development in Industry 2007; Academic Research and Development Expenditures: FY 2008; Federal Funds for Research and Development: FY 2007–09
10© 2010 Innovaro, Inc.
The university has a mission
To Recruit, Reward, and Retain Faculty and/or Researchers
Maximizing Public Good (social return)– Transfer of technology for society’s use
and benefit
Publish, Publish, Publish
To Teach and to Learn
Fulfil Legal Obligation Under Bayh-Dole
11© 2010 Innovaro, Inc.
The Bayh-Dole Act
The Bayh-Dole Act has allowed universities to own the inventions they make leveraging federal funds.– May issue exclusive licenses
One of the key drivers was to encourage federally funded projects to be made available to the public through licensing to businesses.– University is obligated to commercialize
Small business preference Job creation & economic development focus Revenue received
– Share portion with inventors– Remainder goes into research
12© 2010 Innovaro, Inc.
The university has incentives
Follow-on technology development
Recognition
Additional sponsored research
Royalty income– Recover patent costs– License fees– Equity
Employment opportunities for graduates
Local economic impact
Political support: local, regional, national
13© 2010 Innovaro, Inc.
You can be more “industry friendly” without changing your mission! Understand your prospect’s unique business
drivers and processes– What are their value propositions
Knowledge, Service, Ease, Security
What is their interest in your technology?– Source of new technology– Lower cost product development– Patent position – exclusivity– Easier to raise investment capital– Shorter time-to-market– Low-cost access to technical expert
14© 2010 Innovaro, Inc.
Know your client’s decision-maker
Industry Persona– Wei-Li, Head of Global
R&D– Future CEO– Tasked with defending
and spending an R&D budget to maximize shareholder value
– P&L Responsibility Hurdle rate for projects Annual P&L for R&D
Best kind of projects: High return, low risk
Wei-Li’s options– Fund internal projects– License university tech– Buy an IP spinoff– Invest in a startup– Hire a research team– Order an external
research competition
15© 2010 Innovaro, Inc.
Technology - its really about the value proposition Take the time to investigate the
technology value as perceived by the potential client– Consider the odds of obtaining a patent– Value of risk still existing after you patent?– How many technologies does a company
have to invest in to fill their pipeline?– How many technologies move into a
company’s stage-gate process?– How many technologies make it through
the stage-gate process to become a product?
– How many products make money for the company?
– What are the odds of success?
16© 2010 Innovaro, Inc.
Why is industry risk-adverse?
50-65% of invention disclosures from U.S. universities are converted into U.S. Patent applications. (Association of University Technology Managers, AUTM Licensing Survey (various years) and Science and Engineering Indicators 2008)
30-50% of U.S. Patent applications are converted into Utility Patents. (Association of University Technology Managers, AUTM Licensing Survey (various years) and Science and Engineering Indicators 2008)
99.8% of inventions fail. Only 3,000 patents out of 1.5 million are commercially viable. (Richard Maulsby, Director of the Office of Public Affairs for the U.S. Patent and Trademark Office)
17© 2010 Innovaro, Inc.
Perform your due diligence
Universities expect due diligence on the part of Industry partners to bring new university-created technology and intellectual property to the market.
Universities do not want to license new technology only to see it put on hold in order to force the market or protect the company’s market share for an existing product.
Ask - Do they have the ability to commercialize your technology?
18© 2010 Innovaro, Inc.
And help your partner perform theirs
Industry is in complete agreement on both points– They want to understand the value of their options– They want to avoid unnecessary costs
Assist them with ready documentation, notes, drawings, publications, patent info
Work to meet their timelines and be available for questions, teleconferences, site visits
19© 2010 Innovaro, Inc.
Market forces drive technology decisions
Society Inputs
Economic Inputs
Technology Availability
Now to x Years x Years to y Years x Years to y Years x Years +
Base Line
Consumer Needs Green Needs Price Consciousness Fashion Obsolesce XXX
Degree of Change & Impact Effect
No Toxicity Low Water Use No Petroleum Low Waste
Improvement toward desired material characteristics
Current Statistics Manufacturing Limits Costs XXX
Technologies Used Late Stage Technology
Development Research Programs
Early Stage Development Mature Research
Independent Research Sponsored Research
Desired Technologies
Environmental Inputs
Geopolitical Inputs
CompetitiveInputs
Initiate now to create desired materials
Degree of Change & Impact Effect
Degree of Change & Impact Effect
+or+ +
- - -+
or+ +
- - -- - -or
+ + ++ + ++ + +- - -- - -- - -
or
+ + ++ + ++ + +- - -- - -- - -- - -- - -- - -- - -- - -
+ + ++ + ++ + ++ + +- - -- - -- - -- - -
or
+ + ++ + ++ + ++ + ++ + ++ + ++ + ++ + ++ + ++ + ++ + +
- - -- - -- - -- - -- - -- - -- - -- - -
or
Green Requirements Waste Factors Water Consumption Recycling XXX
Alignment?Alignment?Alignment? Alignment?Alignment?Alignment?
Government Regulation Emerging Economies Global Unrest XXX
Alignment?Alignment?Alignment? Alignment?Alignment?Alignment?
Focus areas Leaders & lagers Cost positions XXX
Alignment?Alignment?Alignment? Alignment?Alignment?Alignment?
Alignment?Alignment?Alignment? Alignment?Alignment?Alignment?
Immature Technology Immature Research
Degree of Change & Impact Effect
Degree of Change & Impact Effect
Degree of Change & Impact Effect
Degree of Change & Impact Effect
Degree of Change & Impact Effect
Degree of Change & Impact Effect
Degree of Change & Impact Effect
Degree of Change & Impact Effect
Degree of Change & Impact Effect
Decision CriteriaDecision CriteriaDecision CriteriaDecision Criteria
20© 2010 Innovaro, Inc.
Don’t destroy the prototype!– Ask the inventor: Can you build a more advanced
prototype?
Understand material testing requirements
Provide data if available– Ask the inventor: Can you provide test data?
Evaluate the technology– Federal grant priorities do not reflect market priorities– Leverage tools and resources available to the commercial
market
Incubate the technology
De-risk to assist your industry partner
21© 2010 Innovaro, Inc.
Apply IP valuation techniques Cost Approach
– Historical development costs
Market Approach– Market comparables, Fair Market Value pricing between a
willing seller and buyer.
Income Approach– Present Value of Discounted Cash Flows, Venture Capital
Method (fixed non-market discount rate)
Relief from Royalty Approach– Income deprival of not owning the IP
Real Options Method– Black-Scholes Option Pricing Model
22© 2010 Innovaro, Inc.
Utilize free technology evaluation resources Harvard Business School Baker Library
– http://www.library.hbs.edu/guides/– Industry research guide to free and pay sources
Patent Lens– http://www.patentlens.net/– Find competing inventions; print family diagrams
Web search for industry players– “market share” and [product category]
Trade magazines, Wall Street analyst reports– Does your university give you free access?
23© 2010 Innovaro, Inc.
License terms: flexibility is key It’s not us versus them
Some caution is OK, but start early to develop trust
Your potential partner understands your desire to publish your work
Your potential licensee does not want to steal your work, they want a product that enables them to grow in the marketplace at a reasonable price and minimal risk
Leverage your agreements and agree to the best terms available
Preparation includes market analysis and current deal structures– You’re the seller, shouldn’t you know what it’s worth?
24© 2010 Innovaro, Inc.
Collaboration - an ongoing relationship
Develop long term relationships– Be willing to accommodate the changing research
needs of the industry client
Offer alternative research
Successful partnership should support the ongoing missions of both parties and is best done with a long term relationship that fosters these missions.
25© 2010 Innovaro, Inc.
After the deal – stay connected
Remember Business drivers change– Both negatively and positively
Companies prefer to work with what they understand
To manage costs, companies have to manage resources
You’re in a good position to find new opportunities to work together
26© 2010 Innovaro, Inc.
University incubators & start-ups 2006 US incubators 1,115 up from 12 in 1980
555 U Start-ups formed in 2007, 595 Start-ups in 2008, 7.2% growth in a slowing economy.
3,381 startup companies still operating as of the end of FY2008
Historically, 87% of incubator graduates stay in business
8 percent of all university startups go public compared to 0.07% for other US enterprises
Technology based incubators account for 39% of the 1400 total in North America in 2006
27© 2010 Innovaro, Inc.
Int. J. Entrepreneurship and Innovation Management, Vol. 3, Nos. 1/2, 2003
US Incubator Growth
12 40
595
850
1115
0
200
400
600
800
1000
1200
1980 1985 1995 2003 2006
28© 2010 Innovaro, Inc.
University of Washington TTO Model Announces in 2010 name change to the University of Washington Center
for Commercialization (UWC4C). ”A name can simply mean a lot about a mission” Linden Rhoads, Vice Provost for UWC4C
Their attitude: “We want to help researchers engage with industry early; perhaps long before any intellectual property has been developed. We want to help researchers understand industry needs in their field of research” Fiona Wills, Director of Technology Licensing
Hiring Industry Relations Managers to bridge the communication gap between UW research and industry.
New Programs: – Entrepreneur-In-Residence to support the migration of technology
from research labs to commercial endeavors.
– Commercialization Gap Fund to fund and support projects that the UWC4C believes have a high chance of being commercialized and where gap funding can accelerate the commercialization process.
Information taken from University of Washington Center for Commercialization website and press releases.
29© 2010 Innovaro, Inc.
Success Stories
Recombinant DNA Technology– Developed at Stanford and UC, San Francisco by Stanley Cohen and Herbert
Boyer in 1974– Has been licensed to over 200 companies, generating over $100 million in
royalties– Catalyzed the first successful biotech company, Genentech.
Allegra– Popular antihistamine developed by Georgetown University’s Raymond
Woosley in 1992– Global sales of $1.87B USD in 2004
Cochlear Implants– Hearing device developed by Michael Merzenich at UC, San Francisco– Led to the founding of Advanced Bionic in 1993– Advanced Bionic currently remains a world leader in cochlear implant
technology